During the past decade, Calvary Mater Newcastle conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 45 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 26 clinical trials were completed. i.e. 54.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Calvary Mater Newcastle" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 24 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "BeiGene" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "Australasian Gastro-Intestinal Trials Group" with 7 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Calvary Mater Newcastle" #1 collaborator was "Trans Tasman Radiation Oncology Group" with 9 trials as a collaborator, "Breast International Group" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Peter MacCallum Cancer Centre, Australia" with 6 trials as a collaborator and "Astellas Pharma Inc" with 4 trials as a collaborator. Other collaborators include 173 different institutions and companies that were collaborators in the rest 129 trials.

According to Clinical.Site data, the most researched conditions in "Calvary Mater Newcastle" are "Breast Cancer" (19 trials), "Prostate Cancer" (12 trials), "Multiple Myeloma" (9 trials), "Melanoma" (7 trials) and "Acute Myeloid Leukemia" (6 trials). Many other conditions were trialed in "Calvary Mater Newcastle" in a lesser frequency.

Most popular intervention types in "Calvary Mater Newcastle" are "Drug" (152 trials), "Radiation" (39 trials), "Biological" (22 trials), "Other" (12 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Cisplatin" (10 trials), "Radiotherapy" (10 trials), "Rituximab" (9 trials) and "Cyclophosphamide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Calvary Mater Newcastle" are 135 trials for "All" genders, 23 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 90 active trials in "Calvary Mater Newcastle". 2 are not yet recruiting, 37 are recruiting, 50 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 66 completed trials in Calvary Mater Newcastle, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Calvary Mater Newcastle, 18 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".